This study will examine outcomes for patients treated by planned culotte stenting and compare outcomes with 2 different stent platforms, the next generation Synergy II and the Xience Xpedition DES platforms.
- Composite measure of Adverse events [ Time Frame: 9 months ]
Composite of: Death, Myocardial Infarction, CVA, Target Vessel Failure (Composite of Target Vessel Revascularization and Target Vessel Inadequacy), Definite or Probable stent thrombosis (ARC criteria ), Binary angiographic restenosis
Full services – CERIC Sponsor:
- Final report,
UK & Ireland managed by CERC.
9 centers managed by CERC.